JOHN PAPPAJOHN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN PAPPAJOHN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN PAPPAJOHN. JOHN PAPPAJOHN is 10% Owner in HOOPER HOLMES INC ($HH) and Director in CAREGUIDE INC ($PATY) and Director in MYnd Analytics, Inc. ($CNSO) and Acting Chief Executive Officer in American CareSource Holdings, Inc. ($GNOW) and CEO and Chairman in American CareSource Holdings, Inc. ($GNOW) and Director in American CareSource Holdings, Inc. ($GNOW) and Director in CANCER GENETICS, INC ($CGIX) and President in Kura Oncology, Inc. ($KURA).
Latest Insider Trading Transactions of JOHN PAPPAJOHN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GNOW, PATY, MYND, HH, KURA, CGIX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 23 2019 | MYND | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 1.25 | 200,000 | 250,800 | 1,117,925 | 917.9 K to 1.1 M (+21.79 %) |
Mar 14 2019 | MYND | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 1.68 | 100,000 | 167,600 | 917,925 | 817.9 K to 917.9 K (+12.23 %) |
Feb 01 2019 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.23 | 1,000,000 | 230,000 | 4,781,204 | 3.8 M to 4.8 M (+26.45 %) |
Jan 16 2019 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.23 | 1,000,000 | 225,000 | 3,781,204 | 2.8 M to 3.8 M (+35.96 %) |
Jan 16 2019 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.23 | 1,000,000 | 225,000 | 3,781,204 | 2.8 M to 3.8 M (+35.96 %) |
Oct 10 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 1.38 | 30,000 | 41,400 | 832,925 | 802.9 K to 832.9 K (+3.74 %) |
Sep 25 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 2.00 | 135,135 | 270,270 | 135,135 | |
Sep 25 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 2.00 | 135,135 | 270,270 | 135,135 | |
Sep 25 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 1.85 | 135,135 | 250,000 | 802,925 | 667.8 K to 802.9 K (+20.24 %) |
Sep 25 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 1.85 | 135,135 | 250,000 | 802,925 | 667.8 K to 802.9 K (+20.24 %) |
Aug 28 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 1.63 | 50,000 | 81,500 | 667,790 | 617.8 K to 667.8 K (+8.09 %) |
Aug 28 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 1.62 | 50,000 | 81,000 | 617,790 | 567.8 K to 617.8 K (+8.81 %) |
May 30 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 2.27 | 4,500 | 10,215 | 567,790 | 563.3 K to 567.8 K (+0.80 %) |
May 30 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 2.27 | 4,500 | 10,215 | 567,790 | 563.3 K to 567.8 K (+0.80 %) |
Apr 02 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 2.34 | 500,000 | 1,170,000 | 500,000 | |
Apr 02 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 2.34 | 500,000 | 1,170,000 | 500,000 | |
Apr 02 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 1.88 | 500,000 | 937,500 | 500,000 | |
Apr 02 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 1.88 | 500,000 | 937,500 | 500,000 | |
Jan 08 2018 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 3.44 | 10,000 | 34,378 | 563,290 | 553.3 K to 563.3 K (+1.81 %) |
Dec 11 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 1.86 | 150,000 | 279,000 | 2,781,204 | 2.6 M to 2.8 M (+5.70 %) |
Oct 02 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 2.75 | 5,000 | 13,750 | 5,000 | |
Oct 02 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 2,500 | 0 | 2,631,204 | 2.6 M to 2.6 M (+0.10 %) |
Sep 21 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 3.60 | 12,000 | 43,200 | 12,000 | |
Sep 21 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 12,000 | 0 | 553,290 | 541.3 K to 553.3 K (+2.22 %) |
Aug 18 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 3.28 | 20,000 | 65,560 | 2,628,704 | 2.6 M to 2.6 M (+0.77 %) |
Aug 18 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 3.24 | 66,185 | 214,108 | 2,608,704 | 2.5 M to 2.6 M (+2.60 %) |
Aug 10 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 3.34 | 5,000 | 16,684 | 541,290 | 536.3 K to 541.3 K (+0.93 %) |
Aug 03 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 3.65 | 5,000 | 18,242 | 536,290 | 531.3 K to 536.3 K (+0.94 %) |
Jul 26 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 4.00 | 5,000 | 19,996 | 531,290 | 526.3 K to 531.3 K (+0.95 %) |
Jul 25 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 4.20 | 5,000 | 20,993 | 526,290 | 521.3 K to 526.3 K (+0.96 %) |
Jul 25 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 4.30 | 5,000 | 21,500 | 521,290 | 516.3 K to 521.3 K (+0.97 %) |
Jul 19 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 4.54 | 5,000 | 22,695 | 516,290 | 511.3 K to 516.3 K (+0.98 %) |
Jul 19 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 4.40 | 5,000 | 22,000 | 511,290 | 506.3 K to 511.3 K (+0.99 %) |
Jun 12 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 3.75 | 100,000 | 374,870 | 2,542,519 | 2.4 M to 2.5 M (+4.09 %) |
Jun 08 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 4.15 | 10,000 | 41,500 | 10,000 | |
Jun 08 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 2,500 | 0 | 2,442,519 | 2.4 M to 2.4 M (+0.10 %) |
May 17 2017 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 3.80 | 19,310 | 73,318 | 2,440,019 | 2.4 M to 2.4 M (+0.80 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.85 | 59 | 50 | 1,750,930 | 1.8 M to 1.8 M (0.00 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.85 | 474 | 403 | 1,750,871 | 1.8 M to 1.8 M (+0.03 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.85 | 12,125 | 10,306 | 1,750,397 | 1.7 M to 1.8 M (+0.70 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.75 | 3,186 | 2,388 | 1,738,272 | 1.7 M to 1.7 M (+0.18 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.75 | 4,300 | 3,225 | 1,735,086 | 1.7 M to 1.7 M (+0.25 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.75 | 20,077 | 15,050 | 1,730,786 | 1.7 M to 1.7 M (+1.17 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.75 | 1,400 | 1,047 | 1,710,709 | 1.7 M to 1.7 M (+0.08 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.75 | 700 | 525 | 1,709,309 | 1.7 M to 1.7 M (+0.04 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.75 | 336 | 252 | 1,708,609 | 1.7 M to 1.7 M (+0.02 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.74 | 15,852 | 11,795 | 1,708,273 | 1.7 M to 1.7 M (+0.94 %) |
Apr 21 2017 | HH | HOOPER HOLMES INC | PAPPAJOHN JOHN | 10% Owner | Buy | P | 0.73 | 100,000 | 72,660 | 1,692,421 | 1.6 M to 1.7 M (+6.28 %) |
Apr 06 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 6.46 | 9,878 | 63,843 | 506,290 | 496.4 K to 506.3 K (+1.99 %) |
Mar 22 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 6.25 | 40,000 | 250,000 | 496,412 | 456.4 K to 496.4 K (+8.76 %) |
Feb 14 2017 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 6.25 | 32,000 | 200,000 | 456,412 | 424.4 K to 456.4 K (+7.54 %) |
Dec 30 2016 | MYAN | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 6.25 | 16,000 | 100,000 | 424,412 | 408.4 K to 424.4 K (+3.92 %) |
Dec 02 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 6.25 | 32,000 | 200,000 | 408,412 | 376.4 K to 408.4 K (+8.50 %) |
Nov 29 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 1.45 | 100,000 | 145,280 | 2,420,709 | 2.3 M to 2.4 M (+4.31 %) |
Nov 16 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 1.48 | 31,100 | 46,050 | 2,320,709 | 2.3 M to 2.3 M (+1.36 %) |
Nov 02 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 20,000 | 0 | 376,412 | 356.4 K to 376.4 K (+5.61 %) |
Oct 24 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 8.50 | 200 | 1,700 | 356,412 | 356.2 K to 356.4 K (+0.06 %) |
Oct 19 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 8.00 | 1,000 | 8,000 | 356,212 | 355.2 K to 356.2 K (+0.28 %) |
Oct 14 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 7.50 | 16 | 120 | 355,212 | 355.2 K to 355.2 K (0.00 %) |
Oct 13 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 1.81 | 10,000 | 18,100 | 10,000 | |
Oct 13 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 2,500 | 0 | 2,289,609 | 2.3 M to 2.3 M (+0.11 %) |
Oct 12 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | P | 6.45 | 1,839 | 11,867 | 355,196 | 353.4 K to 355.2 K (+0.52 %) |
Sep 23 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Buy | M | 5.00 | 290,498 | 1,452,490 | 353,357 | 62.9 K to 353.4 K (+462.14 %) |
Sep 20 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Gift | G | 0.00 | 6,538,258 | 0 | 12,571,699 | 19.1 M to 12.6 M (-34.21 %) |
Aug 17 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 2.29 | 45,000 | 103,203 | 2,287,109 | 2.2 M to 2.3 M (+2.01 %) |
Aug 16 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 2.20 | 79,722 | 175,636 | 2,242,109 | 2.2 M to 2.2 M (+3.69 %) |
Aug 16 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 2.10 | 67,778 | 142,652 | 2,162,387 | 2.1 M to 2.2 M (+3.24 %) |
Aug 11 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 0.05 | 2,000,000 | 100,000 | 28,000,000 | |
Jul 25 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 0.05 | 5,000,000 | 250,000 | 26,000,000 | |
Jul 05 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 46,112 | 9,222 | 6,278,672 | 6.2 M to 6.3 M (+0.74 %) |
Jun 30 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 13,800 | 2,760 | 6,232,560 | 6.2 M to 6.2 M (+0.22 %) |
Jun 29 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 26,453 | 5,291 | 6,245,213 | 6.2 M to 6.2 M (+0.43 %) |
Jun 29 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 5,000 | 1,000 | 6,218,760 | 6.2 M to 6.2 M (+0.08 %) |
Jun 27 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 26,500 | 5,300 | 6,213,760 | 6.2 M to 6.2 M (+0.43 %) |
Jun 27 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 27,000 | 5,400 | 6,187,260 | 6.2 M to 6.2 M (+0.44 %) |
Jun 23 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.19 | 11,909 | 2,256 | 6,160,260 | 6.1 M to 6.2 M (+0.19 %) |
Jun 23 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.18 | 20,600 | 3,708 | 6,148,351 | 6.1 M to 6.1 M (+0.34 %) |
Jun 23 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.19 | 11,909 | 2,256 | 6,160,260 | 6.1 M to 6.2 M (+0.19 %) |
Jun 23 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.18 | 20,600 | 3,708 | 6,148,351 | 6.1 M to 6.1 M (+0.34 %) |
Jun 21 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 5,383 | 1,077 | 6,127,751 | 6.1 M to 6.1 M (+0.09 %) |
Jun 14 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 29,148 | 5,830 | 6,122,368 | 6.1 M to 6.1 M (+0.48 %) |
Jun 13 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 53,000 | 10,600 | 6,093,220 | 6 M to 6.1 M (+0.88 %) |
Jun 08 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 4,500 | 900 | 6,040,220 | 6 M to 6 M (+0.07 %) |
Jun 01 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 32,363 | 6,473 | 6,035,720 | 6 M to 6 M (+0.54 %) |
May 31 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 15,000 | 3,000 | 6,003,357 | 6 M to 6 M (+0.25 %) |
May 27 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 72,211 | 14,442 | 5,988,357 | 5.9 M to 6 M (+1.22 %) |
May 26 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | P | 2.25 | 158,910 | 357,548 | 158,910 | |
May 26 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.00 | 317,820 | 0 | 2,099,609 | 1.8 M to 2.1 M (+17.84 %) |
May 25 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 25,008 | 5,002 | 5,916,146 | 5.9 M to 5.9 M (+0.42 %) |
May 24 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 71,878 | 14,376 | 5,891,138 | 5.8 M to 5.9 M (+1.24 %) |
May 23 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.20 | 59,000 | 11,800 | 5,819,260 | 5.8 M to 5.8 M (+1.02 %) |
May 20 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Buy | P | 0.17 | 100,000 | 17,420 | 5,760,260 | 5.7 M to 5.8 M (+1.77 %) |
Apr 07 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 250,000 | 0 | 19,109,957 | 18.9 M to 19.1 M (+1.33 %) |
Apr 04 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 0.05 | 5,000,000 | 250,000 | 16,000,000 | |
Apr 04 2016 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Director | Grant | A | 0.41 | 493,500 | 199,966 | 5,660,260 | 5.2 M to 5.7 M (+9.55 %) |
Mar 17 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 2.64 | 50,000 | 132,060 | 1,771,789 | 1.7 M to 1.8 M (+2.90 %) |
Mar 16 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 2.62 | 10,579 | 27,734 | 1,721,789 | 1.7 M to 1.7 M (+0.62 %) |
Mar 16 2016 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 2.52 | 89,421 | 225,144 | 1,711,210 | 1.6 M to 1.7 M (+5.51 %) |
Apr 13 2016 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 0.05 | 5,000,000 | 250,000 | 21,000,000 | |
Dec 28 2015 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 0.05 | 6,000,000 | 300,000 | 11,000,000 | |
Dec 28 2015 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 0.05 | 5,000,000 | 250,000 | 5,000,000 | |
Dec 11 2015 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Acting Chief Execut ... | Option Exercise | A | 0.88 | 2,857,142 | 2,499,999 | 2,857,142 | |
Dec 11 2015 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Acting Chief Execut ... | Grant | A | 0.00 | 2,857,142 | 0 | 5,166,760 | 2.3 M to 5.2 M (+123.71 %) |
Nov 16 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | P | 5.00 | 100,000 | 500,000 | 100,000 | |
Nov 16 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.00 | 100,000 | 0 | 1,621,789 | 1.5 M to 1.6 M (+6.57 %) |
Oct 16 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 7.80 | 10,000 | 78,000 | 10,000 | |
Oct 16 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 2,500 | 0 | 1,521,789 | 1.5 M to 1.5 M (+0.16 %) |
Sep 04 2015 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Acting Chief Execut ... | Option Exercise | A | 1.70 | 150,000 | 255,000 | 150,000 | |
Sep 01 2015 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | Acting Chief Execut ... | Grant | A | 0.00 | 10,000 | 0 | 2,289,398 | 2.3 M to 2.3 M (+0.44 %) |
Aug 27 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 10.25 | 2,500 | 25,624 | 1,519,289 | 1.5 M to 1.5 M (+0.16 %) |
Aug 27 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 8.97 | 2,500 | 22,436 | 1,516,789 | 1.5 M to 1.5 M (+0.17 %) |
Aug 24 2015 | CNSO | MYnd Analytics, In ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 0.06 | 250,000 | 13,750 | 250,000 | |
May 18 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 10.74 | 5,000 | 53,700 | 1,519,289 | 1.5 M to 1.5 M (+0.33 %) |
Apr 27 2015 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | CEO and Chairman | Option Exercise | M | 0.93 | 18,744 | 17,488 | 0 | |
Apr 27 2015 | GNOW | American CareSourc ... | PAPPAJOHN JOHN | CEO and Chairman | Buy | M | 0.93 | 18,744 | 17,488 | 2,279,398 | 2.3 M to 2.3 M (+0.83 %) |
Mar 18 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 7.15 | 15,000 | 107,237 | 1,514,289 | 1.5 M to 1.5 M (+1.00 %) |
Mar 18 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 7.45 | 35,000 | 260,586 | 1,499,289 | 1.5 M to 1.5 M (+2.39 %) |
Mar 10 2015 | KURA | Kura Oncology, Inc ... | PAPPAJOHN JOHN | President | Sell | D | 0.00 | 2,000,000 | 0 | 0 | 2 M to 0 (-100.00 %) |
Feb 20 2004 | PATY | CAREGUIDE INC | PAPPAJOHN JOHN | Director | Option Exercise | J | 10.00 | 151,475 | 1,514,750 | 424,206 | |
Feb 20 2004 | PATY | CAREGUIDE INC | PAPPAJOHN JOHN | Director | Option Exercise | P | 10.00 | 188,724 | 1,887,240 | 188,724 | |
Feb 20 2004 | PATY | CAREGUIDE INC | PAPPAJOHN JOHN | Director | Option Exercise | G | 10.00 | 22,500 | 225,000 | 27,500 | |
Feb 20 2004 | PATY | CAREGUIDE INC | PAPPAJOHN JOHN | Director | Option Exercise | J | 10.00 | 28,220 | 282,200 | 28,220 | |
Feb 20 2004 | PATY | CAREGUIDE INC | PAPPAJOHN JOHN | Director | Gift | G | 0.00 | 165,000 | 0 | 2,765,060 | 2.9 M to 2.8 M (-5.63 %) |
Feb 20 2004 | PATY | CAREGUIDE INC | PAPPAJOHN JOHN | Director | Buy | P | 1.68 | 2,706,604 | 4,547,095 | 2,930,060 | 223.5 K to 2.9 M (+1,211.25 %) |
Page: 1